Monogram Technologies Inc. logo

Monogram Technologies Inc. (MGRM)

Market Closed
7 Oct, 20:00
NASDAQ (CM) NASDAQ (CM)
$
6. 00
-0.11
-1.8003%
$
243.79M Market Cap
- P/E Ratio
- Div Yield
1.78M Volume
-0.61 Eps
$ 6.11
Previous Close
Investors:
Add Transaction
Day Range
6 6
Year Range
1.92 6.42
Want to track MGRM and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

MGRM closed Tuesday lower at $6, a decrease of -1.8003% from Monday's close, completing a monthly increase of 1.5228% or $0.09. Over the past 12 months, MGRM stock gained 150%.
MGRM is not paying dividends to its shareholders.
The last earnings report, released on Nov 13, 2025, exceeded the consensus estimates by 0.11%. On average, the company has surpassed earnings expectations by 0.0783%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on one exchange.

MGRM Chart

People also search for

OmniAb Inc.
$ 0.09
+11.2485%
IKT
Inhibikase Therapeutics Inc.
$ 2.35
+0.8584%
Amarin Corporation plc Sponsored ADR
$ 13.81
+1.9188%
Compass Therapeutics Inc.
$ 2.08
+0.4831%
Eledon Pharmaceuticals Inc.
$ 3.57
-0.2793%
Monogram Technologies Inc. (MGRM) Shareholder/Analyst Call Prepared Remarks Transcript

Monogram Technologies Inc. (MGRM) Shareholder/Analyst Call Prepared Remarks Transcript

Monogram Technologies Inc. (NASDAQ:MGRM ) Shareholder/Analyst Call September 30, 2025 1:00 PM EDT Company Participants Benjamin Sexson - Chairman of the Board, President & CEO Conference Call Participants Dean Colucci Presentation Benjamin Sexson Chairman of the Board, President & CEO Good morning. Welcome to the Special Meeting of Stockholders for Monogram Technologies, Inc. My name is Benjamin Sexson, and I am the Chairman of the Board of Directors of Monogram.

Seekingalpha | 10 months ago
Monogram Technologies Inc. (MGRM) Q1 2025 Earnings Call Transcript

Monogram Technologies Inc. (MGRM) Q1 2025 Earnings Call Transcript

Monogram Technologies Inc. (NASDAQ:MGRM ) Q1 2025 Earnings Conference Call May 14, 2025 4:30 PM ET Company Participants Larry Holub - Investor Relations Noel Knape - Chief Financial Officer Ben Sexson - Chief Executive Officer Conference Call Participants Jason Wittes - ROTH Capital Tom Kerr - Zacks Larry Holub Good afternoon, everyone, and welcome to the Monogram Technologies First Quarter 2025 Financial Results and Business Update Conference Call. A question-and-answer session will follow the formal presentation.

Seekingalpha | 1 year ago
Monogram Technologies Inc. (MGRM) Q4 2024 Earnings Call Transcript

Monogram Technologies Inc. (MGRM) Q4 2024 Earnings Call Transcript

Monogram Technologies Inc. (NASDAQ:MGRM ) Q4 2024 Earnings Conference Call March 11, 2025 4:30 PM ET Company Participants Larry Holub - Investor Relations Benjamin Sexson - Chief Executive Officer Noel Knape - Chief Financial Officer Conference Call Participants Jason Wittes - ROTH MKM Tom Kerr - Zacks Small-Cap Research Larry Holub Good afternoon everyone. I'm Larry Holub, Director at MZ North America, and would like to welcome you to the Monogram Technologies fourth quarter and full year 2024 financial results and business update conference call.

Seekingalpha | 1 year ago

Monogram Technologies Inc. Investors

Name Quantity Cost Value Profit ($) Gain (%)
MC
Mike Clark Cassady Schiller Wealth Management LLC
1,000 $2,440 $6,000 $3,560 145.9%

Monogram Technologies Inc. (MGRM) FAQ

What is the stock price today?

The current price is $6.00.

On which exchange is it traded?

Monogram Technologies Inc. is listed on NASDAQ (CM).

What is its stock symbol?

The ticker symbol is MGRM.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 243.79M.

Has Monogram Technologies Inc. ever had a stock split?

No, there has never been a stock split.

Monogram Technologies Inc. Profile

Health Care Technology Industry
Healthcare Sector
Benjamin Sexson CEO
NASDAQ (CM) Exchange
609786108 CUSIP
US Country
27 Employees
- Last Dividend
- Last Split
18 May 2023 IPO Date

Overview

Monogram Orthopaedics, Inc., originally known as Monogram Arthroplasty Inc., underwent a name change in March 2017 and was established in 2015, with its headquarters stationed in Austin, Texas. The company emerges as an innovator in the healthcare sector, focusing on enhancing the field of orthopedic surgery through the development of advanced technological solutions. This initiative aims at providing patient-optimized orthopedic implants that promise improved surgical outcomes and patient comfort. Monogram Orthopaedics, Inc. dedicates itself to revolutionizing the way reconstructive joint replacement procedures are performed by integrating cutting-edge robotics, software, and precision-engineered implants.

Products and Services

Monogram Orthopaedics, Inc. offers a spectrum of products and services designed to enhance the efficacy and precision of orthopedic surgeries. These include:

  • Robotic Surgical Equipment: The company has developed robotic systems intended for use in orthopedic surgeries, particularly reconstructive joint replacement procedures. These robots are engineered to execute optimized surgical paths, ensuring high-precision implant insertion.
  • Related Software: Alongside its robotic systems, Monogram Orthopaedics provides specialized software solutions. These software tools are essential for planning surgical procedures, simulating outcomes, and operating the robotic surgical equipment efficiently.
  • Orthopedic Implants: A major focus of Monogram Orthopaedics is the design and production of orthopedic implants that are optimized for each patient. This tailor-made approach aims to improve the fit and function of implants, thereby enhancing the overall success of joint replacement surgeries.
  • Tissue Ablation Tools: The company also markets tools for tissue ablation, which are crucial during orthopedic surgeries to remove damaged or diseased tissue with precision, minimizing harm to surrounding healthy tissue.
  • Navigation Consumables: These are auxiliary tools and materials used in conjunction with the company’s robotic systems and software to guide the surgeon through the procedure, ensuring accuracy and efficiency.
  • Miscellaneous Instrumentation: Monogram Orthopaedics provides a range of additional instruments necessary for joint replacement surgeries. These tools support the comprehensive needs of orthopedic surgeons during procedures.

Contact Information

Address: 3913 Todd Lane
Phone: 512 399 2656